Cita APA

Lin, J., Wu, H., Shi, H., Pan, W., Yu, H., & Zhu, J. (2013). Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Leads to Greater Anti-tumor Activity of Docetaxel in Advanced Prostate Cancer. Public Library of Science.

Citación estilo Chicago

Lin, Jianzhong, Hongfei Wu, Hui Shi, Wei Pan, Hongbo Yu, y Jiageng Zhu. Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Leads to Greater Anti-tumor Activity of Docetaxel in Advanced Prostate Cancer. Public Library of Science, 2013.

Cita MLA

Lin, Jianzhong, et al. Combined Inhibition of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Leads to Greater Anti-tumor Activity of Docetaxel in Advanced Prostate Cancer. Public Library of Science, 2013.